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A B S T R A C T
DNA methylation (DNAm) – an epigenetic process that regulates gene expression – may represent a mechanism
for the biological embedding of early traumatic experiences, including childhood maltreatment. Here, we
conducted the first systematic review of human studies linking childhood maltreatment to DNAm. In total, 72
studies were included in the review (2008–2018). The majority of extant studies (i) were based on retrospective
data in adults, (ii) employed a candidate gene approach (iii) focused on global maltreatment, (iv) were based on
easily accessible peripheral tissues, typically blood; and (v) were cross-sectional. Two-thirds of studies (n = 48)
also examined maltreatment-related outcomes, such as stress reactivity and psychiatric symptoms. While find-
ings generally support an association between childhood maltreatment and altered patterns of DNAm, factors
such as the lack of longitudinal data, low comparability across studies as well as potential genetic and ‘pre-
exposure’ environmental confounding currently limit the conclusions that can be drawn. Key challenges are
discussed and concrete recommendations for future research are provided to move the field forward.
1. Introduction
Childhood maltreatment is a major neurodevelopmental risk factor
that continues to affect up to one in four children worldwide (World
Health Organisation, 2016). Acts of maltreatment, including abuse and
neglect, represent one of the most toxic forms of childhood adversity,
probabilistically increasing the likelihood of maladaptation and psy-
chopathology across the life span (Toth and Cicchetti, 2013). Children
who are exposed to maltreatment are more likely to develop a range of
social, emotional and behavioral problems, including anxiety, depres-
sion, conduct problems and hyperactivity (Cecil et al., 2017; de Oliveira
et al., 2018; Keyes et al., 2012; Ouyang et al., 2008). Many of these
effects are not confined to childhood but can extend well into the adult
years. Indeed, childhood maltreatment is a robust predictor of lifetime
psychiatric disorders (Caspi et al., 2014), associating not only with the
occurrence of mental health problems per se, but also with an earlier
age of onset, higher comorbidity, greater symptom severity and poorer
response to treatment (e.g. psychological treatment and pharma-
cotherapy such as antidepressant use), when such problems do emerge
(Hovens et al., 2012; Nanni et al., 2012; Nemeroff et al., 2003). Mal-
treatment has also been shown to compromise other important aspects
of individual function, including relationship quality, educational at-
tainment, employment prospects and earnings, as well as physical
health (Danese et al., 2009). Consequently, childhood maltreatment is
recognized as a key target for prevention and intervention efforts
(MacMillan et al., 2009; McCrory and Viding, 2015).
An important question for research, clinical practice and public
health is to understand how childhood maltreatment can increase risk
for negative outcomes even decades after the exposure itself has ceased.
Research suggests that, in part, this enduring effect may be indirectly
mediated by subsequent factors associated with childhood maltreat-
ment, such as exposure to further adversity and revictimization later in
life (e.g., peer victimization, intimate partner violence; Shields and
Cicchetti, 2001) as well as harmful behaviors that may develop as a
result of maltreatment (e.g., substance use; Lansford et al., 2010).
However, growing evidence also points to a more direct pathway,
whereby exposure to severe stressors in childhood, such as maltreat-
ment, becomes ‘biologically embedded’, altering development and
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function in a way that engenders latent vulnerability for poor outcomes
and reduced resilience (McCrory and Viding, 2015). This is supported,
for example, by evidence of numerous biological correlates of child-
hood maltreatment, including neuroendocrine dysregulation, heigh-
tened inflammatory response, alterations in metabolic function, aty-
pical brain structure and function, as well as accelerated cellular ageing
(Berens et al., 2017). Despite increasing knowledge of the biological
sequelae of maltreatment, however, the molecular mechanisms under-
lying these associations remain unclear. In recent years, epigenetic
processes have emerged as a promising mechanism by which early
adverse experiences such as maltreatment may drive biological
changes, shaping long-term trajectories of development, health and
disease risk.
1.1. Epigenetics: a potential mechanism for the biological embedding of
environmental exposures
The ‘epigenome’ refers to a collection of epigenetic processes that
regulate when (i.e. during the lifespan) and where (i.e. in the body)
genes are expressed – primarily via chemical modifications to DNA,
histone proteins, and chromatin structure (Jaenisch and Bird, 2003). Of
these, DNA methylation (DNAm) is currently the most commonly in-
vestigated epigenetic mechanism in human research on early life stress
and psychiatric risk, as it is easier to quantify and relatively more stable
compared to other epigenetic processes (Jones et al., 2018). DNAm
refers to the addition of a methyl molecule to specific DNA base pairs,
primarily in the context of cytosine-guanine (CpG) dinucleotides. Ra-
ther than being randomly distributed across the genome, CpG sites tend
to cluster into ‘CpG islands’ that are often located in the proximity of
gene promoter regions. These islands are typically unmethylated (i.e.
no methyl molecules attached), enabling transcription factors to bind to
the DNA sequence and to subsequently activate gene expression. In
contrast, when methyl groups attach to CpG islands, they physically
impede transcription factors from binding to the DNA sequence,
thereby interfering with gene expression. Overall, the association be-
tween DNAm and gene expression has been found to vary depending on
the gene region examined: whereas higher DNAm levels within gene
promoters and enhancers are usually associated with decreased ex-
pression of that gene, DNAm levels in the gene body region typically
associate with increased gene expression (Jjingo et al., 2012). Im-
portantly, DNAm marks can be mitotically passed on during cell divi-
sion, which can lead to stable alterations in gene activity and down-
stream biological processes.
While it is well established that DNAm patterns are under con-
siderable genetic control – as evidenced by both twin and molecular
genetic studies (e.g., Boks et al., 2009; Zhang et al., 2010) – it is also
increasingly clear that environmental influences play an important role
in epigenetic regulation (Feil and Fraga, 2012). As a result, DNAm has
been posited as a potential mechanism underlying gene-environment
interplay on phenotypic expression. This is supported, for example, by
studies showing that individual differences in DNAm patterns are lar-
gely explained by the joint effect of genes and environments (GxE or G
+ E; Czamara et al., 2019; Teh et al., 2014) – a finding also observed
specifically in relation to childhood maltreatment (Klengel et al., 2013).
Research in animals and humans has found that DNAm patterns as-
sociate with a range of environmental factors beginning as early as in
utero, with some of the strongest evidence implicating tobacco smoking
and nutritional exposures (Breton et al., 2009; Cecil et al.,
2016a,2016b; Richmond et al., 2014b; Rijlaarsdam et al., 2017). These
epigenetic ‘signatures’ can persist long after the exposure itself, sup-
porting a role of DNAm in the biological embedding of environmental
influences. For example, in an often-cited study, Heijmans et al. (2008)
found that even 60 years after the event had taken place, individuals
who had been prenatally exposed to famine (i.e. severe undernutrition)
showed lower levels of DNAm in the Insulin-Like Growth Factor 2
(IGF2) gene – a key regulator of fetal development – and higher disease
risk compared to their unexposed, same-sex sibling. In another study,
Richmond et al. (2014b) reported that although some of the DNAm
marks associated with prenatal exposure to maternal tobacco smoking
were reversible with time, others persisted into adulthood, with po-
tentially long-term consequences for health. Similarly, in adults, DNAm
patterns have been found to differentiate between never-smokers, ex-
smokers and current smokers, as cessation leads to reversibility of some,
but not all, smoking-related DNAm changes, even decades after cessa-
tion (Ambatipudi et al., 2016). Of relevance to the maltreatment field,
growing evidence suggests that, in addition to these more ‘physical’
exposures, DNAm patterns may also be sensitive to ‘social’ exposures,
such as the quality of the early caregiving environment (e.g., Barker
et al., 2018).
1.2. Early adversity and DNA methylation: evidence from animal and
human studies
The first evidence for the impact of early adversity on the epi-
genome stemmed from research in animals. In a series of seminal stu-
dies based on rodents, Weaver and colleagues (2004; 2005) found that
variations in maternal care during the first week of life – as indexed by
either high (i.e. nurturing care) or low (i.e. poor/neglectful care) levels
of licking and grooming – led to long-term changes in the pup’s epi-
genetic regulation of a gene crucially implicated in HPA axis function:
the Glucocorticoid Receptor gene (Nr3c1). In turn, these epigenetic
changes stably altered Nr3c1expression, resulting in variations in the
density of glucocorticoid receptors in the brain as well as inter-in-
dividual differences in the pup’s physiological and behavioral responses
to future stressors. Remarkably, the authors demonstrated that while
epigenetic programming by maternal care could persist into adulthood,
it could be reversed by early intervention, such as methionine infusion
or cross-fostering (Weaver et al., 2004, 2005). Since these early reports,
multiple other studies in animals have supported a link between early
adversity and DNAm, reporting higher Nr3c1 methylation in pups ex-
posed to poor maternal care as well as other stressful experiences, such
as maternal separation (see Turecki and Meaney, 2016, for a review).
Together, this research has led to a major interest in the role of
DNAm as a potential biological mediator of early adversity on devel-
opmental outcomes in humans, with a particular focus on the effects of
childhood maltreatment. The first study that sought to translate animal
findings into humans was that of McGowan and colleagues (2009), who
examined NR3C1methylation levels in hippocampal tissue from suicide
completers. The authors found that, amongst adults who had com-
mitted suicide, those retrospectively identified as having experienced
maltreatment during childhood showed higher levels of NR3C1 me-
thylation in the hippocampus – consistent with the findings from pups
exposed to low maternal licking and grooming. As reviewed by Turecki
and Meaney (2016), subsequent studies have since replicated associa-
tions between childhood maltreatment and elevated NR3C1 methyla-
tion with a high degree of consistency, not only in postmortem brain
tissue but also extending findings to peripheral tissues (e.g. saliva,
blood) in living individuals. Furthermore, a number of studies have
found that higher NR3C1 methylation also associates with maltreat-
ment-relevant outcomes, including physiological markers of stress re-
sponse (e.g. cortisol reactivity; van der Knaap et al., 2015), en-
dophenotypes of psychiatric risk (e.g. neural responses to trauma-
related intrusive memories; Vukojevic et al., 2014), and clinical out-
comes (e.g. diagnosis of borderline personality disorder [BPD], major
depression and post-traumatic stress disorder [PTSD]; Dammann et al.,
2011; Yehuda et al., 2015) – although null results have also been re-
ported (see Turecki and Meaney, 2016 review).
In summary, studies in humans seem to support animal findings in
showing that (i) early psychosocial adversity in the form of childhood
maltreatment can influence epigenetic regulation of the NR3C1 gene;
and that (ii) changes in NR3C1 methylation, in turn, associate with
stress-related physiological and psychiatric outcomes. As the field
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moves forward, however, there is an increasing appreciation that, if we
are to gain a more complete picture of how childhood maltreatment
influences epigenetic regulation, we must look beyond the NR3C1 gene
and examine wider changes in DNAm across the genome. This is well-
reflected in the rapidly growing number of studies examining the re-
lationship between childhood maltreatment and DNAm across other
candidate genes (e.g. SLC6A4, FKBP5, BDNF, OXTR), as well as emer-
ging research using hypothesis-free, genome-wide approaches. While
studies have already been reviewed concerning (i) associations between
other types of stressors and DNAm (e.g. prenatal stress: Sosnowski et al.,
2018; chronic adult stress: Bakusic et al., 2017); or (ii) broadly-defined
early life stress and epigenetic changes in specific genes (e.g. NR3C1:
Turecki and Meaney, 2016; SLC6A4: Provenzi et al., 2016), no sys-
tematic review exists to date on the topic of childhood maltreatment
and DNA methylation.
1.3. The current review
Here, we conducted the first systematic review of research ex-
amining the relationship between childhood maltreatment and DNA
methylation. Specifically, we collated findings from existing human
studies in this area, irrespective of approach (e.g. candidate vs genome-
wide), tissue (e.g. brain vs peripheral tissues), age range assessed (e.g.
childhood, adolescents, adults), and sample type (e.g. general popula-
tion, community high-risk samples, psychiatric inpatients). Epigenetic
mechanisms other than DNAm (e.g. histone modifications and non-
coding RNAs) were excluded, as these remain rarely investigated in
human populations due to challenges with sample storage and proces-
sing (Jones et al., 2018). Based on the studies identified, we evaluate
the current state of the literature, highlight main challenges for the field
and propose key recommendations for future research.
2. Methods
Searching and reporting of results followed the general re-
commendation from the PRISMA 2009 revision (Moher et al., 2009;
Peng et al., 2018).
2.1. Inclusion and exclusion criteria
The current systematic review included studies that investigated
associations between DNAm and childhood maltreatment. To search for
all studies conducted in this area, we included articles published at any
time before the 1st of January 2019. Inclusion criteria were as follows:
(1) studies must report empirical evidence (reviews were excluded); (2)
they must focus on human populations (animal studies were excluded);
(3) they must examine childhood maltreatment, such as abuse and/or
neglect (studies that examined a global index of adversities or other
childhood stressors, such as poverty, institutionalization and parental
psychopathology were excluded, unless they also reported specific as-
sociations with maltreatment; studies measuring exposure to mal-
treatment and life stressors after childhood were also excluded); (4)
they must measure DNAm levels (other epigenetic mechanisms, such as
histone modifications, were excluded); and (5) they must not be solely
based on cell-lines. Additionally, studies were excluded if they were
conference papers, book chapters, or written in non-English languages.
No restrictions were applied regarding: (1) tissue type (e.g. peripheral
or central tissue), (2) sample age (e.g., childhood, adulthood), (3) re-
search design (e.g., longitudinal, cross-sectional), (4) approach (e.g.
candidate vs genome-wide), and (5) whether or not a phenotypic out-
come was also included (e.g., cortisol levels, depression, brain func-
tion).
2.2. Search strategy
Four electronic databases (PubMed, Web of Knowledge, Medline,
and EMBASE) were searched for relevant studies written in English.
Search terms were applied in MeSH or index terms, as well as text
words. Included terms related to either (i) DNA methylation, AND (ii)
childhood maltreatment (i.e., child* maltreat*, child* abuse, child*
neglect, child* deprivation, child* advers*, child* trauma), NOT (iii)
type of manuscript (review, commentary), NOT (iv) animal studies
(mice, mouse, animal, rat).
2.3. Study selection & eligibility assessment
Studies were first screened based on the title and abstract. Those
that appeared to meet inclusion criteria were then retrieved for full-text
screening to assess eligibility. Three independent reviewers screened
the articles. Data fields assessed were (1) exposure; (2) phenotype/
outcome; (3) sample characteristics (e.g., age, gender, clinical vs.
general population); (4) tissue (e.g., saliva, blood); (5) study design
(e.g., cross sectional, longitudinal); (6) DNAm time points assessed (1 or
more); and (7) approach (candidate, EWAS, global DNAm).
3. Results
3.1. Descriptive summary
Our search yielded 866 records, with 547 remaining after filtering
out duplicates (see Fig. 1). Titles and abstracts were then screened, and
of these, 459 were excluded for the following reasons: not empirical
(e.g. reviews, n = 165), conference papers and book chapters (n = 80),
did not measure DNAm (n = 8), did not examine childhood maltreat-
ment (n = 125) or examined childhood maltreatment only in combi-
nation with other types of adversities (e.g. poverty; n = 49), were
animal studies (n = 26), or written in non-English languages (n = 6).
88 studies were retained, and their full-text articles were assessed for
eligibility. 16 articles were removed at this stage due to the following
reasons: (i) 9 did not report associations specifically with childhood
maltreatment, (ii) 1 was a conference paper, (iii) 3 did not focus on
DNAm, (iv) 1 was a methods paper, (v) 1 was a preprint on BioRixv, and
(vi) 1 focused on childhood stressors other than maltreatment. A total
of 72 original reports were included in the systematic review. 24% (n =
17) of included studies were published in 2018 alone, and sample sizes
were on average modest (n = 142) ranging between n = 24 and n =
1658 (see Fig. 2). Full details of these studies are provided in Supple-
mentary Table 1.
3.2. Global DNA methylation
A total of three studies examined the relationship between childhood
maltreatment and global DNAm levels (i.e. where one score is calculated
per individual indexing overall DNAm levels), showing weak evidence of
associations. In a mixed sample of psychiatric patients, Murphy et al.
(2013) found no association between global DNAm (assessed via 5-mC
quantification) and childhood sexual/physical abuse, although global hy-
permethylation was observed in individuals who had attempted suicide
compared to those who did not. Other forms of maltreatment were not
assessed. Similarly, Smith et al. (2011) did not identify an association
between global DNAm (assessed by averaging all sites on the Illumina27k
array) and childhood abuse in a sample of adults with a diagnosis of PTSD
vs controls. In a more recent study, Misiak et al. (2015) examined global
DNAm levels (via LINE-1 repetitive elements) in patients with first-onset
schizophrenia and observed higher DNAm for patients who reported early
life trauma vs those without a trauma history. Follow-up analyses in-
dicated that this association was mainly driven by experience of emotional
abuse. While all three studies used DNA extracted from whole blood in
adults, they differed in a number of characteristics which may explain
differences in findings, including the method for quantifying global
DNAm, the classification of childhood maltreatment and the psychiatric
population examined.
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3.3. Epigenetic age
DNAm patterns strongly associate with chronological age, to the
extent where methylation-based algorithms have been developed that
can predict age with a high degree of accuracy, as well as enabling
researchers to use residuals from these models to calculate age ‘accel-
eration’ (i.e. when epigenetic-predicted age is greater than chron-
ological age, a difference that is hypothesized to reflect advanced bio-
logical aging). Three studies used the approach developed by Horvath
(2013) to investigate associations between childhood maltreatment and
accelerated epigenetic age, with mixed findings. Zannas et al. (2015)
found that cumulative lifetime stress, but not childhood maltreatment
or current stress alone, predicted accelerated epigenetic aging (based on
blood) in an urban, African American cohort of 392 participants,
pointing to a potential mechanism through which chronic stress may
accelerate biological aging and increase age-related disease risk (e.g.
coronary heart disease). A second study by Lawn et al. (2018) found no
association between epigenetic age and a range of childhood stressors
(e.g. global maltreatment, socioeconomic position, parental psycho-
pathology, illness) amongst adult women from two population-based
cohort studies in the UK, the Avon Longitudinal Study of Parents and
Children (ALSPAC; n = 989; DNAm drawn from blood at two time
points) and the National Survey of Health and Development study
(NSHD; n = 773; DNAm from buccal cells at a single time point). A
specific association between sexual abuse and accelerated epigenetic
age was identified in ALSPAC across the two time points tested, but this
could not be ascertained in NSHD as only global maltreatment was
measured in that sample. Finally, O’Donnell et al. (2018), did not
identify any significant associations between childhood maltreatment
and epigenetic age acceleration (measured from blood) in a sample of
188 individuals who were born to mothers either randomly assigned to
a control group or a psychosocial intervention program (the authors
also conducted epigenome-wide analyses, which are described in the
relevant section below).
Fig. 1. PRISMA flowchart detailing the filtering steps undertaken to select studies.
Fig. 2. Publication trend of papers investigating DNAm in maltreated popula-
tion.
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3.4. Candidate gene studies
As shown in Table 1, 51 studies examined the relationship between
childhood maltreatment and DNAm level using a candidate gene ap-
proach, whereby specific genes are pre-selected for analysis based on an
existing hypothesis. Almost half of all candidate gene studies focused on
NR3C1 (n = 23), followed by SLC6A4 (n = 8), FKBP5 (n = 6), BDNF (n
= 4), OXTR (n = 3),MAOA (n = 2) and 5-HT3A (n = 2). Twelve other
genes were investigated only once. Below, we focus on genes that have
been examined at least twice. Full details of the 51 individual studies
are listed in Supplementary Table 1, whereas an overview of findings
from the most widely examined candidate genes is provided in Table 2).
3.4.1. HPA axis and neuroendocrine pathway genes
3.4.1.1. Glucocorticoid receptor (NR3C1) gene. NR3C1 encodes the
glucocorticoid receptor (GR), to which cortisol and other
glucocorticoids bind. As a transcription factor (and modulator of
other transcription factors), GRis involved in a wide range of
developmental, immune and endocrine processes. In the field of
maltreatment, however, it has gained wide attention specifically
because of its key role in regulating stress responses within the brain
(Turecki and Meaney, 2016). Candidate epigenetic studies on childhood
maltreatment have primarily focused on the NR3C1 gene guided by
early evidence from animal experimental models. These have mainly
examined the promoter region exon 1F – the human equivalent of exon
17 shown to be differentially methylated in animals exposed to early
adversity – although other regions have also been tested (Shields et al.,
2016). For example, Suderman et al. (2012) used a cross-species
approach to examine NR3C1 DNAm levels in postmortem
hippocampal tissue of rats exposed to early life stress and humans
exposed to maltreatment during childhood. The authors identified a
similar pattern of hypermethylation of the NR3C1 promoter in exposed
rats and humans, as well as finding consistent DNAm alterations across
the wider NR3C1 gene locus, thereby supporting a conserved epigenetic
mechanism of stress response between species. In line with these
findings, 17 of the 23 studies on the NR3C1 gene (74 %) identified in
this review reported increased DNAm in relation to exposure to
childhood maltreatment, namely physical, emotional, and sexual
abuse or neglect (Bustamante et al., 2016; Cicchetti and Handley,
2017; Farrell et al., 2018; Labonte et al., 2012b; Martin-Blanco et al.,
2014; McGowan et al., 2009; Parade et al., 2016; Parent et al., 2017;
Peng et al., 2018; Perroud et al., 2011; Radtke et al., 2015; Romens
et al., 2015; A. E. Shields et al., 2016; Suderman et al., 2012; Tyrka
et al., 2015a, 2012; van der Knaap et al., 2014), whereas one reported
decreased methylation levels (Tyrka et al., 2016) and 5 other studies
reported null associations (Hecker et al., 2016; Steiger et al., 2013; E.
Vangeel et al., 2015, 2018). It is important to note, however, that
several of the NRC31 studies were based on the same samples and
research groups, and thus not all were independent. Furthermore, the
criteria for significance varied considerably, with studies differing in
the number of CpG sites analyzed and whether multiple testing
correction was used. Nevertheless, the overall consistency in findings
is notable, with associations between childhood maltreatment and
NR3C1 hypermethylation reported across different types of samples
(clinical, community), age groups (children, adolescents and adults),
maltreatment measures (self-report, official records) and biological
tissues (blood, saliva, brain).
In addition to maltreatment status, hypermethylation of NR3C1 has
also been found to relate to the specific characteristics of maltreatment
exposure, with associations more evident for maltreatment that occurs
at an earlier age of onset and is more severe and chronic (Cicchetti and
Handley, 2017; Perroud et al., 2011). Only one study measured DNAm
at multiple time points, showing that the relationship between mal-
treatment and NR3C1 methylation can be complex and dynamic over
time. Specifically, Parent et al. (2017) examined DNAm within 6
months of documentation of maltreatment and then again after one
year. The authors found that although maltreatment status associated
with NR3C1 hypermethylation at baseline, it was also associated with
decreased methylation levels over time, emphasizing the importance of
longitudinal designs, the need to consider the timing of epigenetic
Table 1
Summary of study characteristics.
Study characteristics (N = 72) N %
Design
Cross-sectional 63 88%
Prospective/longitudinal 9 13%
Developmental period
Childhood 13 18%
Adolescence 4 6%
73+Adulthood 48 67%
Postmortem 7 10 %
Replication
No 68 94%
Yes 4 6%
Maltreatment type examined
Any/global maltreatment 49 68 %
Abuse only (physical and/or sexual) 23 32%
DNAm approach
Candidate 51 71%
Hypothesis-free 17 24 %
Global 2 3%
Epigenetic age 2 3%
DNAm tissue
Peripheral blood 46 64%
Saliva 18 25%
Buccal 5 7%
Brain (postmortem) 7 10 %
Sperm 1 1%
Repeated measures of DNAm
No 66 92%
Yes 6 8%
Psychiatric and physiological outcomes
No 22 31%
Yes 50 69%
Most commonly investigated:
Depression 15 21%
Borderline Personality Disorder 9 13%
Suicide and suicidal ideation 9 13%
Cortisol (e.g. baseline, reactivity) 5 7%
Post-Traumatic Stress Disorder 3 4%
Anxiety 4 6%
Eating disorders 3 4%
N.B. The total number of studies for each characteristic may exceed 72 dues to
the presence of studies fitting multiple domains.
Table 2
Summary of study characteristics and results for the most commonly in-
vestigated candidate genes.
Gene N studies (%
out of 51)
Main region of
interest
Association with child maltreatment
Positive Negative Null
NRC31 23 (45 %) Exon 1 F 17 1 5
SLC6A4 8 (16 %) Promoter 7 0 1
FKBP5 6 (12 %) Intron 7 (GRE) 0 4 2
BDNF 4 (8%) Different
regions
2 1 1
OXTR 3 (6%) Promoter 2 0 1
MAOA 2 (4%) Different
regions
1 1 0
5-HT3A 2 (4%) Different
regions
1 1 0
N.B. GRE: glucocorticoid response element region; Not all studies per category
are independent; Classification is based on significance (threshold set by in-
dividual studies). The total number of studies for each gene differs from 51 due
to the presence of studies examining multiple candidate genes. Also, studies
examining genes that were investigated only once are not shown in the table.
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assessment and the presence of potential moderating environmental
factors following maltreatment.
In order to investigate the potential functional consequences of
maltreatment-related NR3C1 methylation changes, a number of studies
also included information on downstream biological markers, such as
gene expression levels and physiological measures of stress response.
Based on postmortem hippocampal samples, two studies found that
NR3C1 hypermethylation associated with reduced gene expression le-
vels amongst maltreatment-exposed individuals, supporting the hy-
pothesis that maltreatment affects regulation of key stress-related genes
via DNAm changes (e.g., Labonte et al., 2012a; McGowan et al., 2009).
However, none of the studies using peripheral tissues in living in-
dividuals measured both NR3C1 methylation and expression, so that it
is unclear whether these functional effects generalize to non-CNS tissue,
such as saliva or blood. With regards to physiological markers of HPA
axis, findings so far have been mixed, with reports of both positive and
negative associations of NR3C1 methylation with measures of basal
cortisol levels and cortisol reactivity (Alexander et al., 2018; Farrell
et al., 2018; Tyrka et al., 2012). For example, Farrell et al. (2018) re-
ported that, in a sample of depressed patients, levels of NR3C1 pro-
moter methylation at one CpG site in exon 1F positively associated with
both severity of emotional abuse and morning cortisol concentrations
(indicative of higher basal HPA axis activity), which the authors in-
terpreted as an indication of acquired glucocorticoid receptor re-
sistance. Focusing on cortisol response rather than basal levels,
Alexander et al. (2018) found that, amongst healthy individuals ex-
posed to moderate to high levels of maltreatment, DNAm of the NR3C1
exon 1F promoter moderated stress response to the Trier Social Stress
Test. Specifically, within this group, individuals with high DNAm levels
showed 62 % higher cortisol levels following stress exposures compared
to those with low DNAm. In contrast, Tyrka et al. (2012) found that
increased NR3C1 promoter methylation associated with an attenuated
cortisol response to the dexamethasone/corticotropin releasing hor-
mone (Dex/CRH) test in a sample of 88 healthy adults, although more
recently the same research group found a positive association between
NR3C1 promoter methylation and post-Dex/CRH cortisol response in a
larger sample of 231 healthy adults (Tyrka et al., 2016). Although these
studies are not necessarily in conflict with those examining stress ac-
tivation – as Dex activity is primarily situated in the pituitary (which
lies outside the blood-brain barrier) rather than neurally mediated
(Cole et al., 2000) – general inconsistencies in findings mirror those
observed in the broader literature on maltreatment and cortisol. Indeed,
such research has previously identified heightened as well as blunted
cortisol function and reactivity following maltreatment exposure,
pointing to the likely complex relationship between maltreatment and
indices of HPA axis activity (Bernard et al., 2017).
Finally, 16 (70 %) of studies on this gene have included information
on mental health outcomes, in order to clarify the relevance of mal-
treatment-related NR3C1 methylation changes for risk of psycho-
pathology. Unlike the consistency of effects observed for maltreatment
and NR3C1 methylation, however, associations with psychopathology
have been more mixed. On the one hand, maltreatment-related NR3C1
hypermethylation has been found to positively associate with sympto-
matology, such as internalizing symptoms in children (Cicchetti and
Handley, 2017; Parade et al., 2016; Tyrka et al., 2015a) and multiple
psychiatric outcomes in adulthood, including depression (Peng et al.,
2018), aspects of BPD (particularly self-harm; Martin-Blanco et al.,
2014), and bulimic syndromes, especially when accompanied by
marked impulse-dysregulation and mood instability (Steiger et al.,
2013). On the other hand, other studies based on clinical populations
with elevated rates of maltreatment exposure have identified negative
associations between NR3C1 methylation and psychopathological out-
comes. For instance, in two independent samples of female patients
with chronic fatigue syndrome (CFS) versus controls, Vangeel and
colleagues (2015; 2018) found evidence of hypomethylation with
emotional abuse only amongst CFS patients, however, no significant
association was found between DNAm levels and trauma history after
multiple testing correction.
Overall, only three of these studies explicitly tested the joint effects
of maltreatment and NR3C1 methylation on psychiatric outcomes, ei-
ther via moderation or mediation analyses. Radtke et al. (2015) re-
ported a significant interaction effect between childhood maltreatment
and NR3C1 methylation in predicting risk of psychopathology. With
regards to mediation, Peng et al. (2018) found that together with BDNF
- another candidate gene – NR3C1 methylation levels mediated close to
20 % of the association between childhood maltreatment and self-re-
ported depression scores in adults. In contrast, Cicchetti et al. (2017)
found no evidence of mediation of NR3C1 methylation on the asso-
ciation between maltreatment exposure to psychopathology in children,
despite the individual paths being significant.
3.4.1.2. FK506 binding protein 5 (FKBP5) gene. The FKBP5 gene,
located on the short arm of chromosome 6 (6p21.31), is a co-
chaperone of NR3C1 that regulates its sensitivity and response to
stressors. FKBP5 and NR3C1 operate together in a complex, negative
feedback loop. On the one hand, when FKBP5 binds to the
glucocorticoid receptor (GR) complex, it reduces the ability of GR to
bind to cortisol, resulting in decreased GR signaling and translocation
to the nucleus. On the other hand, the FKBP5 gene contains
glucocorticoid response elements (GRE) in intron 7, which enable GR
binding to in turn regulate its expression (Zannas et al., 2016). Higher
activation of FKBP5 has been found to associate with increased stress-
sensitivity and psychiatric risk (Wiechmann et al., 2019). Furthermore,
genetic polymorphisms in FKBP5 have been shown to interact with
environmental exposures, including maltreatment, to predict
psychiatric outcomes in both human and animal studies (Zannas
et al., 2016).
Six epigenetic studies on childhood maltreatment focused on
FKBP5. Four of these studies consistently reported decreased FKBP5
methylation in the intron 7 region (coinciding with a glucocorticoid
response element) in children and adults exposed to childhood mal-
treatment (Klengel et al., 2013; Parade et al., 2017; Tozzi et al., 2018;
Tyrka et al., 2015b), although two studies in adults found no significant
association (Bustamante et al., 2018; Farrell et al., 2018). Four of the
six studies also measured FKBP5 genotype to test genetic moderation:
two reported significant hypomethylation amongst exposed individuals
carrying the risk allele (Klengel et al., 2013; Tozzi et al., 2018), whereas
the other two found no significant interaction effects (Tyrka et al.,
2015a,2015b; Parade et al., 2017). As with the NR3C1 gene, only one
study assessed the levels of FKBP5 at multiple time points and found
that while maltreatment status was associated with hypomethylation at
baseline, it did not associate with changes in DNAm a decade later,
when participants had entered early adulthood (Parade et al., 2017).
However, the presence of additional adversities was found to influence
this relationship: children who were exposed to maltreatment and other
types of adversities showed persistently low DNAm levels across time.
3.4.1.3. Oxytocin receptor (OXTR) gene. Oxytocin is a hormone and
neuropeptide that has been implicated in a range of social behaviors
(e.g. empathy, bonding, attachment) and in modulating the individual’s
sensitivity to the social environment (Bartz et al., 2011). The Oxytocin
Receptor (OXTR) gene, located on chromosome 3, is expressed both in
the brain and within peripheral organs, where it synthesizes oxytocin
receptors. Genetic and epigenetic variation in OXTR has been found to
associate with individual differences in prosociality and maladaptive
behaviors linked to early adversity (Maud et al., 2018). Based on our
review, we identified three studies examining the relationship between
OXTR methylation and childhood maltreatment, with weak evidence
for an association (Gouin et al., 2017; Kogan et al., 2018; Smearman
et al., 2016). In a sample of 393 African American adults, Smearman
et al. (2016) found that childhood abuse associated with increased
OXTR methylation in 4 out of 18 CpG sites investigated, but this
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association did not survive multiple testing correction. Variation in
OXTR did, however, associate with nearby single nucleotide
polymorphisms, supporting genetic influences. Furthermore, while
OXTR methylation did not mediate the link between childhood
maltreatment and psychopathology (indexed by depression and
anxiety symptoms), maltreatment status significantly interacted with
DNAm to predict psychopathology. The second study, by Gouin et al.
(2017), compared DNAm from a small sample of adults who were
followed longitudinally from childhood, and who were either exposed
to maltreatment (n = 24) or not (n = 22). The authors reported that
the exposed group showed higher levels of OXTR methylation in a CpG
site in the promoter region, although this difference did not survive
multiple correction. Stratified analyses by gender revealed stronger
associations between maltreatment exposure and OXTR methylation in
females compared to males. Finally, Kogan et al. (2018), followed a
cohort of 358 young African American men over three time points
spanning late adolescence into early adulthood. Despite the lack of
evidence for the hypothesized association between childhood trauma
and OXTR methylation, they identified a distal influence of
maltreatment that carries forward through more proximal social ties.
Specifically, childhood trauma was associated with changes in prosocial
ties between the first and second time point, which in turn predicted
OXTR methylation.
3.4.2. Neurodevelopmental and neurotransmitter pathway genes
3.4.2.1. Serotonin transporter (SLC6A4) gene. Serotonin is a major
neurotransmitter in the central nervous system, modulating a range
of important functions, including mood regulation, affective processing
learning and memory. Most epigenetic studies in this area have focused
on the promoter region of SLC6A4 (also known as 5-HTT and SERT), a
14 exon gene located on chromosome 17, encoding the serotonin
transporter. The selection of this gene has been heavily influenced by
experimental and human studies reporting disrupted serotonin function
in response to early life stress, as well as evidence from the gene-
environment interaction literature, which showed that presence of the
SLC6A4 risk allele significantly moderates the effect of childhood
maltreatment risk for depression and other psychiatric disorders –
although these findings have been recently disputed (Border et al.,
2019). Overall, the identified studies suggest a pattern of SLC6A4
promoter hypermethylation in individuals exposed to childhood
maltreatment. However, it is important to note that several of these
studies are based on the same Iowa Adoptee Study, reporting
hypermethylation amongst individuals exposed to sexual abuse
(Beach et al., 2013, 2010, 2011; Vijayendran et al., 2012), or a
combination of sexual and physical abuse (Beach et al., 2010).
Specifically, this set of studies found that the association between
sexual abuse and SLC6A4 methylation was specific to females, possibly
due to the much higher levels of exposure reported by females than
males. Other types of abuse did not associate with SLC6A4 methylation
when examined separately from sexual abuse. The sample in the 2010
report was smaller with participants selected at random for inclusion in
that study. Later reports examined a larger sample reflecting all
available participants.
Drawing on this cohort, Beach et al. (2013) further observed that (i)
sexual abuse and genetic load (indexed via parental psychopathology)
exerted main effects on depressive and antisocial symptomatology of
study participants; (ii) these two factors interacted to predict SLC6A4
methylation levels – supporting DNAm as a potential mechanism un-
derlying previously reported gene-environment interactions; and (iii)
SLC6A4 methylation mediated the effect of sexual abuse on antisocial
psychopathology.
Reports from the other four studies are generally consistent with the
above. Two support the finding of elevated DNAm in individuals ex-
posed to childhood maltreatment (Booij et al., 2015; Kang et al., 2013).
Specifically, Kang and colleagues found that physical abuse and sexual
abuse were both significantly associated with higher methylation of the
SLC6A4 promoter region, measured as the average methylation level
across 81 CpG sites, with physical abuse showing stronger associations.
Similarly, Booij and colleagues found that global maltreatment asso-
ciated with hypermethylation of the SLC6A4 promoter, and that these
effects were mainly driven by physical abuse. One other study in twins
found nominal associations between childhood maltreatment and in-
creased SLC6A4 methylation, but these did not survive multiple cor-
rection. In contrast, the last study investigated a broad range of ad-
versities in 133 Caucasian participants including childhood
maltreatment and concluded that there was no significant effect of
stress on the mean SLC6A4 methylation levels (Wankerl et al., 2014).
3.4.2.2. Serotonin 3A receptor gene (HTR3A). Aside from the serotonin
transporter, two studies examined the HTR3A serotonin receptor gene.
HTR3A encodes a ligand-gated ion channel which, in humans and
animals, has been shown to be involved, amongst other processes, in
neural circuit formation, the regulation of amygdala excitability and
fear extinction. Furthermore, in humans, genetic variations in the
HTR3A have been shown to interact with early-life adversity to
regulate serotonergic activity (Jang et al., 2015). In a sample of 346
patients with psychiatric diagnoses of ADHD, BPD and bipolar disorder,
Perroud et al. (2016) found that childhood maltreatment, especially
physical abuse, was associated with higher severity of all three
disorders (indexed by number of mood episodes, history of suicide
attempts, and previous hospitalization), and that this effect was
mediated by higher DNAm at two CpG sites in HTR3A (drawn from
blood). In contrast, Schechter et al. (2017) found a negative association
between exposure to childhood maltreatment and HTR3A promoter
methylation, extracted from saliva, in a sample of 35 women who were
either diagnosed with PTSD vs controls. The authors interpreted these
discrepant findings as reflecting differences underlying the
pathophysiology of PTSD versus the mood disorders examined by
Perroud et al.
3.4.2.3. Monoamine oxidase A (MAOA). codes for a mitochondrial
enzyme involved in metabolizing neurotransmitters, chief amongst
them serotonin and dopamine. The gene contains a functional VNTR
polymorphism in the promotor region that has been widely examined in
relation to psychopathology, including risk for antisocial behavior,
aggression and depression – disorders for which childhood
maltreatment has been established as part of multifactorial etiologies.
Checknita et al. (2018) found evidence for an association between
sexual abuse and hypermethylation of the MAOA first exon region in a
female sample (without such a pattern occurring in relation to physical
abuse). These DNAm levels were also found to mediate the relationship
between sexual abuse and depression (but not other
psychopathologies). In contrast, the study in twins by Peng et al.
(2018) did not identify any independent association between childhood
maltreatment and MAOA methylation, although joint effects were
observed together with the four other candidate genes under
investigation (NR3C1, BDNF, SLC6A4 and MAOB).
3.4.2.4. Brain-derived neurotrophic factor (BDNF) gene. BDNF has
recurrently been implicated in neuronal cell proliferation and survival,
and synaptic activity. BDNF has also been found to modulate risk for
various psychopathologies, by acting on biological mechanisms such as
neuroplasticity, inflammation or hypothalamic–pituitary–adrenal (HPA)
axis functionality, all processes that are sensitive to stress exposure
(Miskolczi et al., 2019). The neurotrophin has also been linked with
food-related energy homeostasis and the risk for eating disorders. Thaler
et al. (2014) found increased DNAm at specific CpG sites in individuals
with Bulimia nervosa as compared to controls. This association was
stronger in individuals who had been exposed to child abuse and/or
individuals with BPD psychopathology. Perroud et al. (2013) examined
BDNF promotor methylation in a psychotherapy intervention study for
patients with BPD. DNA methylation at CpG sites located in exons I and IV
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was significantly higher in patients than controls, and childhood abuse
severity predicted higher levels of BDNFmethylation pre-therapy. Therapy
non-responders showed a significant BDNF methylation increase post-
therapy, whereas responders were characterized by a decrease. Clinically,
DNAm changes were associated with changes in depression, hopelessness
and impulsivity scores. In a separate study based on patients with
depression, Wang et al. (2018) found that maltreatment history
associated with lower BDNF DNAm levels. In addition, BDNF
hypomethylation and its interaction with stressful life event scores were
linked impaired antidepressant (escitalopram) treatment response.
Specifically, those patients who did not show remission/response to
antidepressants had significantly lower DNAm than those who did, at
baseline. The same was found for those patients with less symptom
improvement, who showed lower DNAm at follow-up than those with
more improvement. In those responding to antidepressant use, there was a
significant increase in DNAm from baseline to follow-up. No significant
relationships to childhood trauma for the follow-up component could be
detected, but at baseline, increased childhood trauma was associated with
decreased DNAm. The last study, by Peng et al. (2018), found that global
childhood maltreatment associated with hypermethylation at three BDNF
CpG sites, although associations did not survive multiple correction.
3.7. Hypothesis-free studies
In total, 17 (24 %) studies used a hypothesis-free approach
(Supplementary Table 1). Of these, the majority (n = 14) ran epi-
genome-wide association (EWAS) analyses, where all CpG sites on the
array are tested individually for associations with maltreatment to
identify differentially methylated positions (DMPs). The remaining
three studies used data reduction strategies to decrease the di-
mensionality of the data, including principal component analysis, gene-
set analysis, and epigenome-wide regional analysis to identify differ-
entially methylated regions (DMRs; i.e. sets of adjacent or physically
proximal CpGs significantly associated with maltreatment exposure).
Here, we first discuss research based on children and adolescents, be-
fore turning to adults and postmortem studies.
3.7.1. Child studies
Four studies examined child samples, all of which classified pre-
sence of (any) maltreatment based on official records and used the
Illumina 450k array based on DNA extracted from saliva
(Supplementary Table 1). Yang et al. (2013) investigated epigenetic
correlates of maltreatment in a sample of 192 children, who were either
removed from their parents due to substantiated cases of abuse and/or
neglect over the prior 6 months (n = 96) vs demographically-matched
controls (n = 96; age range = 5-14yrs). Neglect was the most common
type of maltreatment recorded, although most children were exposed to
multiple forms of adversity. The authors reported that over 2800 sites
were differentially methylated between groups after genome-wide
correction. These DNAm sites mapped onto genes that were sig-
nificantly enriched for a range of biological processes of relevance to
physical health problems e.g. cancer, although the study did not ex-
plicitly relate DNAm differences to health outcomes. Using the same
sample of children, Weder et al. (2014) further investigated the re-
lationship between DNAm and depression risk in maltreated children.
The authors found that three DNAm sites associated with depression
scores in the entire sample after genome-wide correction, which
mapped onto genes implicated in stress response and neural plasticity
(ID3, TPPP, GRIN1). The site in ID3 also associated with diurnal cortisol
secretion. Overall, these three sites were nominally associated with
maltreatment exposure, as were sites in BDNF, FKBP5 and NR3C1,
based on a candidate gene follow-up analysis. In a separate sample,
Cicchetti, Hetzel, Rogosch, Handley, and Toth (2016) examined epi-
genetic correlates of maltreatment in 548 low-income children (mean
age = 9yrs) who attended a research summer camp program, half of
whom were identified as having experienced maltreatment based on
official records. As with the above studies, neglect was the most pre-
valent form of maltreatment in this sample, and the majority of mal-
treated children experienced multiple forms of abuse/neglect. The
EWAS results indicated that over 1800 sites were differentially me-
thylated between groups after genome-wide correction. Consistent with
Yang et al. (2013), maltreated children generally showed elevated
DNAm levels at low and medium methylation sites, and reduced DNAm
levels at high methylation sites. Also in line with Yang et al., gene
ontology analyses indicated enrichment for disease-relevant processes
as well as mental health-related terms. Specific associations between
DNAm in top sites and maltreatment varied by gender, ethnicity and
developmental timing of exposure. Of note, sites on the X and Y chro-
mosomes were removed from the analysis but sex was not controlled for
in the epigenome-wide analysis, although it has been found to associate
with DNAm levels in autosomes (Suderman et al., 2017). Furthermore,
none of the above studies controlled for cell-type composition in saliva,
which typically includes a mixture of buccal epithelial cells and white
blood cells – as such, it is unclear to what extent these patterns may
simply be reflecting immune cell composition. The last study, by
Kaufman et al. (2018), did not examine associations between mal-
treatment exposure and DNAm directly, but rather modelled their in-
teraction in predicting child BMI amongst 234 children (mean age =
11yrs, 52 % maltreated), split into a discovery (n = 160; Illumina 450k
array) and replication (n = 74, Illumina EPIC array) sample. Ten CpG
sites were found to interact with childhood maltreatment exposure at a
genome-wide level in the discovery sample, including sites previously
implicated in obesity-risk. These findings however did not replicate
based on the EPIC array in the smaller replication sample, although one
CpG site located in the GALE gene showed a trend level interaction. One
CpG site in the PCK2 gene, which associated with BMI across both
samples, was found to mediate the effects of childhood maltreatment on
obesity risk.
3.7.2. Adolescent studies
Two of the identified studies focused on adolescent samples, both
using an EWAS approach. The first, from our group, sought to char-
acterize the DNAm ‘signatures’ of five forms of childhood maltreatment
in a high-risk sample of inner-city youth (buccal cells; n = 124; age
range = 16–24), 68 % of whom reported experiencing maltreatment
while growing up (based on the CTQ; Cecil et al., 2016a,2016b). We
found that physical exposures (i.e. physical abuse and neglect, sexual
abuse) showed the strongest genome-wide associations, implicating
multiple genes previously associated with psychiatric and neurode-
generative disorders (e.g. GABBR1, GRIN2D, CACNA2D4, PSEN2).
Based on gene ontology analyses, we found that although maltreatment
types showed unique DNAm patterns enriched for specific biological
processes (e.g. physical abuse with cardiovascular function, fear pro-
cessing and wound healing vs. physical neglect with nutrient metabo-
lism), they also shared a ‘common’ epigenetic signature enriched for
biological processes related to regulation of nervous system develop-
ment and organismal growth. The second study, by Marzi et al. (2018),
examined associations between different types of victimization and
DNAm in a large population-based study of twins E-risk; n = 1658; age
at blood draw = 18yrs. Overall, the authors found weak and mixed
evidence for a relationship between peripheral DNAm and victimiza-
tion. Using prospective measures of maltreatment, 48 genome-wide
significant associations were identified across individual types of mal-
treatment, 39 of which were related to sexual abuse. When using ret-
rospective measures of maltreatment CTQ – which had only fair
agreement with the prospective measures – another 48 loci were
identified, 22 of which related to sexual abuse. However, these sites did
not overlap with those identified prospectively, and were not replicated
in an independent sample of 818 adults who completed the CTQ within
the Dunedin Longitudinal Study age 38yrs after multiple testing cor-
rection. To complement the genome-wide analyses, the authors also
followed up specific stress-related candidate genes NR3C1, FKBP5,
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BDNF, AVP, CRHR1, SLC6A4), but identified only two associations with
childhood maltreatment after gene-based correction (one locus in BDNF
and one in FKBP5).
3.7.3. Adult studies
Most epigenome-wide studies (n = 11; 65 %) examined associations
between maltreatment and DNAm in adults (Supplementary Table 1).
Here we first summarize studies in living individuals based on high-risk
(n = 6) and general population (n = 3) samples – which mainly
measured DNAm in blood – followed by post-mortem studies in brain
tissue (n = 2). In a psychiatric sample of patients with BPD and co-
morbid MDD, Prados et al. (2015) employed a machine learning ap-
proach to predict maltreatment exposure based on DNAm patterns
(blood) and found that prediction performance was most optimal for
global maltreatment (defined as total number of maltreatment types
reported in the CTQ), as opposed to any individual form of maltreat-
ment alone. The most predictive DNAm site (validated with pyr-
osequencing) was located in the vicinity of MicroRNA 137 (MIR-137),
which is involved in the regulation of neuronal and HPA-related genes,
including NR3C1. Focusing exclusively on the CTQ abuse subscales,
Mehta et al. (2013) examined differential transcriptomic and epigenetic
patterns between individuals in three different groups (i) patients with
PTSD and exposure to abuse (n = 32), (ii) patients with PTSD and no
exposure to abuse (n = 29), and (iii) control individuals without PTSD
who were exposed to trauma, but not abuse (n = 108). Patterns that
were found to associate with abuse exposure did not overlap with those
identified for PTSD. The majority of differentially expressed transcripts
related to child abuse also showed differential DNAm at coinciding
CpGs sites. In contrast to Mehta et al., another study comparing groups
of individuals following a similar operationalization (i.e. PTSD +
abuse, PTSD-abuse, control + abuse, control-abuse; n = 110) found no
significant associations between DNAm and abuse history, although
associations with PTSD were identified (Smith et al., 2011). Marinova
et al. (2017) compared DNAm patterns (buccal cells) between Swiss
elderly individuals who had experienced severe adversity and forced
labor in childhood (n = 30) vs demographically-matched controls (n =
15). Former child laborers reported significantly greater rates of global
maltreatment and differed from controls across 71 DNAm sites, which
were enriched for processes related to neural and organismal devel-
opment (consistent with enriched terms from our study; Cecil et al.,
2016a,2016b). In addition to examining epigenetic age acceleration (as
described in the section above), O’Donnell et al. (2018) carried out
hypothesis-free analyses in their sample of 188 adult offspring of
women randomized to a nurse visitation program, by performing
genome-wide principal component analysis on CpG sites showing high
variability in DNAm levels (defined as having a range ≥ 10 %). The
authors extracted the first 10 principal components, two of which were
found to associate with maltreatment and relate to transcriptional
processes. Associations were partially explained by smoking but not by
polygenic risk scores for psychiatric disorders. One other study also
used principal components analyses to reduce the dimensionality of
epigenome-wide DNAm data. Based on sperm DNAm from three groups
of men exposed to varying degrees of child abuse (n = 34), Roberts
et al. (2019) found that abuse explained over 6% of variance in one of
the top 9 principal components. The authors also identified a number of
DMRs associated with child abuse, with three specific sites found to be
most useful in classifying exposure levels based on machine learning.
Generally, associations between abuse and DNAm were not explained
by factors such as psychiatric disorders, lifetime trauma exposure,
smoking and BMI.
Three studies in adults were based on general population samples.
Based on 40 males from the 1958 National Child Development Study
(NCDS), Suderman et al. (2012) found widespread differences in pro-
moter DNAm (blood) between those who reported childhood abuse vs
controls, with significant enrichment for genes involved in transcrip-
tional regulation and development. Interestingly, these patterns did not
overlap with those associated with low socioeconomic position. The top
hit for childhood abuse (in the PM20D1 gene involved in mitochondrial
function) was validated with pyrosequencing and replicated in an ad-
ditional sample. The second study examined epigenome-wide correlates
(buccal cells; Illumina 450k) of cortisol reactivity in 85 healthy adults
from the general population, and then associated these to global CTQ
maltreatment scores (Houtepen et al., 2016). Although no associations
survived genome-wide correction, the top site (cg27512205, annotated
to KITLG, a gene involved in a range of cellular developmental pro-
cesses) was replicated in two independent samples (buccal cells; blood),
showed concordance with DNAm levels in the brain, and partially
mediated the association between childhood maltreatment and blunted
cortisol reactivity. Of note, a replication attempt by Wrigglesworth
et al. (2018), focusing on KITLG as a candidate gene in an elderly po-
pulation provided further evidence for a link between KITLG methyla-
tion and cortisol under a stress condition, although no association was
identified with childhood trauma. A more recent study by Houtepen
et al. (2018) sought to examine epigenome-wide patterns associated
with adverse childhood experiences, including maltreatment, in women
from two large population-based samples (ALSPAC: n = 780, blood;
NSHD: n = 552, buccal cells). Consistent with the study by Marzi et al.
(2018) in adolescents, the authors identified weak and mixed evidence
for maltreatment-related DNAm effects: DMRs associated with mal-
treatment within each sample were not replicated, and regression
coefficients for the top 1000 CpGs for each analyses were only weakly
correlated between cohorts. Of note, however, DMRs associated with
individual maltreatment types in ALSPAC, such as sexual abuse, could
not be tested in NSHD, as only data on global maltreatment was
available in that sample. Instead, the authors examined sites previously
reported to associate with sexual abuse within a different population
sample, the Dunedin study, and found that these were indeed also en-
riched for sexual abuse in ALSPAC.
Finally, two studies investigated epigenome-wide DNAm patterns in
brain tissue. Based on post-mortem hippocampal tissue from in-
dividuals who had committed suicide (n = 41, of whom 25 with history
of childhood abuse based on psychological autopsies) vs matched
controls, Labonte et al. (2012a) reported group differences across 307
gene promoters, most of which were hypermethylated in abused in-
dividuals. Follow-up analyses in a subset of individuals confirmed that
these patterns of hypermethylation typically associated to decreased
gene expression. A recent study by Lutz et al. (2017) also examined
brain tissue in order to investigate epigenetic, transcriptomic and
morphological correlates of childhood abuse in the anterior cingulate
cortex – a brain region previously found to be altered in maltreated
individuals based on neuroimaging data. The study comprised of 47
suicide completers with major depressive disorder (27 of whom also
experienced childhood abuse) vs 26 matched controls. Drawing on a
highly comprehensive set of analyses, the authors found that in-
dividuals who had experienced childhood abuse differed from controls
across 115 DNAm regions, which were enriched for oligodendrocyte
and myelin-related genes. These epigenetic changes were indeed found
to occur specifically in oligodendrocyte (as opposed to neuronal) po-
pulations, based on cell sorting, and were linked to altered gene ex-
pression. In turn, changes in gene expression were found to correlate
highly with those observed in the brain of adult rats exposed to low
maternal care early in life. Furthermore, the identified epigenetic and
transcriptomic alterations were supported by evidence of reduced white
(but not grey) matter density and decreased myelin axonal thickness in
the child abuse group only. The same patterns were not observed in the
depressed-only group, suggesting that they are not explained by psy-
chopathology.
4. Discussion
In this systematic review, we summarize evidence from a decade
(2008–2018) of human research investigating the relationship between
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childhood maltreatment and DNA methylation. We identified 72 em-
pirical studies, a fourth of which were published in 2018 alone. While
the majority of studies supported an association between childhood
maltreatment and DNAm patterns – with the strongest evidence im-
plicating the NR3C1 gene – the current evidence base is far from con-
sistent, with the strength and direction of associations varying widely
across studies. Inconsistencies are likely to stem in large part from
marked differences in methodology and sample characteristics, which
currently limit the comparability of findings and possibilities for
pooling estimates in meta-analyses. Going forward, it will be necessary
to push towards more open, collaborative and reproducible science (e.g.
via consortium initiatives), in order to increase statistical power, detect
more robust associations and reduce false positives. Although particu-
larly challenging in the context of maltreatment research, the use of
longitudinal and genetically-sensitive designs that can account for a
range of environmental and genetic confounders will also mark an
important step for better delineating the relationship between (different
forms of) childhood maltreatment and DNAm. In this section, we first
begin by summarizing similarities and differences between the identi-
fied studies, before outlining key challenges for the field and setting out
twelve specific recommendations for future research.
4.1. Summary of study characteristics and findings
4.1.1. Study characteristics
In this review we identified a total of 72 empirical studies, the
majority of which (i) employed a candidate gene (i.e. hypothesis-
driven) approach, (ii) examined DNAm from readily-accessible per-
ipheral tissues (e.g. blood, saliva), (iii) used a cross-sectional design
with variables measured at a single time point, (iv) assessed maltreat-
ment history via self-report, and (v) involved adults, typically in the
context of psychiatric samples. While most studies focused on the effect
of overall maltreatment, either classified categorically (e.g. any vs no
exposure; different thresholds or counts of exposure) or continuously
(e.g. via composite or total scores), some examined associations with
specific forms of maltreatment. Of these, physical and sexual abuse
were by far the most assessed. In contrast, neglect was examined the
least, even though it emerged as the most prevalent form of maltreat-
ment within studies that classified exposure based on substantiated
cases from official records (e.g., Cicchetti et al., 2016; Yang et al.,
2013). Furthermore, little attention was paid to emotional abuse, de-
spite growing evidence that this form of maltreatment shows the
strongest independent associations with poor mental health across
symptom domains, raters and gender (Cecil et al., 2017; de Oliveira
et al., 2018). Over two-thirds of studies collected additional informa-
tion on physiological, behavioral and/or psychiatric measures, in order
to examine whether maltreatment-DNAm associations explain in-
dividual differences in stress response and psychiatric risk. These stu-
dies focused primarily on outcomes known to strongly associate with
maltreatment exposure, such as depression, BPD, suicidality, post-
traumatic stress and anxiety as well as alterations in HPA axis func-
tioning. Overall, very few studies included an independent replication
sample or meta-analyzed estimates from different samples. Further-
more, few studies utilized a prospective design, measured DNAm at
repeated time points or assessed the functional effect of maltreatment-
related DNAm changes at different biological levels (e.g. on gene ex-
pression or brain function).
Based on the available data, it is not yet possible to conclusively
assess how exposure to maltreatment – or its subtypes – associates with
DNAm in different genes, and how these associations may vary across
important factors such as timing and chronicity of exposure, age, sex,
tissue type and presence of psychiatric symptoms or other health pro-
blems. A main barrier for this is the high heterogeneity among studies,
both in terms of sample characteristics as well as methodology (e.g. way
of measuring DNAm, type of analysis performed, choice of covariates,
significance threshold used, etc.), which currently limits comparability
of findings. Another issue concerns reporting practices, as key statistics
needed for performing meta-analyses, such as standard errors, are often
not provided. Furthermore, in the case of EWAS studies, in which
hundreds of thousands of different sites across the genome are tested,
only associations that meet a certain threshold of significance are
usually presented (e.g. genome-wide Bonferroni threshold), whereas
full results are seldom provided (e.g. as supplementary material or in a
public repository). As such, it is not currently possible to establish how
convergent the epigenome-wide ‘signatures’ of maltreatment may be
across these hypothesis-free studies. Bearing these limitations in mind,
we highlight here some interesting similarities and differences in
findings that emerged while reviewing the studies, which warrant fur-
ther investigation.
4.1.2. Similarities in findings
A number of candidate genes were investigated by multiple studies
and, promisingly, showed a consistent direction of associations. The
glucocorticoid receptor gene NR3C1 was by far the most extensively
examined, with 17 (74 %) out of 23 studies reporting a positive asso-
ciation between childhood maltreatment and levels of NR3C1 methy-
lation (typically in the Exon 1 F region). Of the five studies that re-
ported null results, two showed a positive direction consistent with the
above, while the other three studies did not include any effect size es-
timates, so that it was not possible to establish the direction of asso-
ciations. The last study reported a negative association between child-
hood maltreatment and adult NR3C1 DNAm, which the authors
interpreted as reflective of the complexity of epigenetic regulation of
this gene in response to maltreatment and other stressors over time.
Overall, the consistency in findings is notable, as positive associations
were identified in studies using different samples (e.g. psychiatric,
community), age ranges (children, adolescents, adults), maltreatment
measures (e.g. self-reported vs official records), and importantly, tissue
types (saliva, blood and postmortem brain [primarily hippocampus]).
Furthermore, the findings are consistent with previous animal experi-
mental work demonstrating the impact of early adversity (quantified as
low maternal licking and grooming) on increased NR3C1 methylation,
with downstream effects on gene expression levels, glucocorticoid re-
ceptor density in the brain as well as physiological and behavioral re-
sponses to future stressors (Turecki and Meaney, 2016).
Another gene that showed promising findings is SLC6A4, coding for
the serotonin transporter. This was the second most commonly in-
vestigated gene after NR3C1, examined by eight studies, all of which
were based on adults, focused on childhood abuse (sexual and/or
physical) and measured DNAm from blood. Seven (87.5 %) of the stu-
dies reported a positive association between childhood maltreatment
exposure and higher SLC6A4 promoter methylation. The remaining
study also identified a positive association, but this did not survive
multiple testing correction. Together, these findings add to the body of
literature from existing genetic, neurophysiological and animal re-
search implicating serotonin neurotransmission in stress response and
susceptibility to psychiatric risk following maltreatment exposure. It is
important to note, however, that in both the case of NR3C1 and
SLC6A4, reported effect sizes were generally small, replication attempts
were low and the functional relevance of the identified DNAm changes
was not tested. As such, it is unclear to what extent reported alterations
impact gene expression levels and downstream biological function in
humans. This is particularly problematic in cases where studies utilized
an average DNAm score across many CpG sites spanning a wide gene
region, as the relationship between DNAm levels at these CpG sites and
gene expression may have varied depending on location, thereby
raising questions about the biological significance of such an approach.
More broadly, concerns have been raised in recent years regarding the
use of a candidate gene approach, particularly from the field of psy-
chiatric genetics, as it is most commonly employed by single studies
with low samples sizes and is more susceptible to publication biases,
false positives and winner’s curse (Border et al., 2019). Such concerns
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underscore the importance of moving towards transparent reporting
and collaborative science, which will be needed if we are to facilitate
meta-analyses, and thus enable us to systematically evaluate the ro-
bustness of these findings.
As with other complex exposures and outcomes, it is unlikely that
epigenetic changes associated with maltreatment are restricted to single
genes in isolation. Rather, such exposures are likely to involve changes
in wider gene networks and pathways. Preliminary support for this
emerged from the results of pathway analyses across several EWAS
studies. Specifically, a number of these hypothesis-free studies found
that maltreatment-related DNAm changes were more likely to occur in
genes involved in neural (e.g. ‘axon guidance’), developmental (e.g.
‘multicellular organismal development’) and cardiovascular processes
(‘cardiac muscle hypertrophy’; Cecil et al., 2016a,2016b; Cicchetti
et al., 2016; Marinova et al., 2017) – consistent with the broader lit-
erature on maltreatment, pointing to the negative effect of abuse and
neglect on these biological systems. Despite these promising findings, it
is not currently possible to systematically compare the results of site-
and pathway-level analyses from EWAS studies, as genome-wide output
is not typically provided. With regards to other findings, there was, in
general, weak evidence for an association of childhood maltreatment
with global DNAm, accelerated epigenetic ageing, and epigenetic var-
iation in other candidate genes, although data is not sufficient at pre-
sent to evaluate this comprehensively.
4.1.3. Differences in findings
Two key discrepancies in findings stand out from our review. The
first concerns differences in findings within EWAS studies. Although
most EWAS studies found genome-wide significant associations be-
tween childhood maltreatment and DNAm, they differed widely from
one another in the number of associations reported (ranging from 1 to
2868) and the specific DNAm sites identified. As mentioned above,
these differences are likely to reflect heterogeneity in sample char-
acteristics (e.g. sample size, which influences statistical power) and
methodology (e.g. choice of covariates). For example, some studies did
not correct for key factors known to influence DNAm levels, such as sex
and cell-type, potentially leading to inflated results. A major source of
difference, however, related specifically to the use of high-risk vs po-
pulation-based samples. While studies from high-risk samples (e.g.
children with substantiated histories of maltreatment, socially dis-
advantaged youth, psychiatric inpatients) typically identified genome-
wide associations between childhood maltreatment and DNAm, studies
using population-based samples did not – or were not able to replicate
the identified associations. A number of factors may explain these dif-
ferences. On the one hand, population-based studies might have been
more robust to false positives, as they were on average considerably
larger than high-risk studies, and typically featured an independent
replication sample. On the other, studies from the general population
may have been less able to detect effects due to lower base rates of
maltreatment exposure in the sample (i.e. more severe cases may be
under-represented due to lower enrolment, higher attrition and loss to
follow-up). Furthermore, maltreatment measures may be less compre-
hensive and precise in population-based studies (e.g. single items,
binary classification of exposure) compared to those utilized in high-
risk studies, leading to more measurement error – an issue that also
posed challenges to the field of genome-wide association studies
(GWAS) prior to the rise of EWAS studies. Greater harmonization of
measures and methodology across high-risk and population-based study
could facilitate collaborative efforts to trace epigenetic correlates of
maltreatment across the full range of exposure.
The second discrepancy concerns differences in findings between
candidate gene and EWAS studies. Specifically, genes selected for
candidate gene studies did not converge with those identified using
hypothesis-free, epigenome-wide approaches. This is well illustrated in
the case of the NR3C1 gene, which, despite being the most commonly
investigated candidate gene in the field (with associations having been
reported across tissues and species), was not identified by any of the
EWAS studies employing an epigenome-wide threshold of significance.
This could indicate that most candidate gene findings are likely to be
false positives, as previously suggested in the field of psychiatric ge-
netics (e.g. Border et al., 2019). However, it is also possible that asso-
ciations between maltreatment and DNAm in candidate genes, such as
NR3C1, are in fact robust, but not strong enough to withstand genome-
wide thresholds of significance. To evaluate these scenarios, it will be
useful in future for EWAS studies to additionally report findings for
candidate genes (either as a follow-up analysis, as done in e.g. Marzi
et al., 2018, or ideally by providing the full EWAS results), which will
make it possible to compare estimates with candidate gene studies as
well the direction and strength of significance.
4.2. Current challenges and recommendations for future research
Below, we present three key challenges for current research, and
propose a set of concrete recommendations for moving the field for-
ward.
4.2.1. Challenge 1: overcoming study heterogeneity to identify more robust
and replicable associations
As discussed above, one of the key challenges for the field concerns
the large heterogeneity between studies, which often feature different
target genes, ways of operationalizing maltreatment, sample char-
acteristics and analytical pipelines. Such differences limit comparability
between studies – a necessary step for assessing more systematically the
evidence base and identifying robust associations. In order to address
this challenge, it will be important to define common practices that
facilitate data harmonization across studies. Four specific re-
commendations for addressing this challenge are provided below:
4.2.1.1. Use dimensional, multi-type measures of maltreatment. Studies
should consider how best to operationalize maltreatment, preferentially
using continuous measures that help to capture the full range of
exposure and maximize statistical power. Where possible, studies
should not examine only global scores of maltreatment, but also
specific types of abuse and neglect (e.g. Cecil et al., 2016a,2016b).
This will make it possible to better establish whether different types of
maltreatment are associated with shared vs unique epigenetic
‘signatures’ – although such efforts are undoubtedly complicated by
the high rate of co-occurrence between maltreatment types, which
would need to be accounted for in analyses (see Challenge 2 below for
more details). Furthermore, collecting information on maltreatment
characteristics (e.g. age of onset, chronicity, recency) will enable in
future to test to what extent these factors moderate observed
associations between maltreatment exposure and DNAm. With
regards to the measures themselves, it is currently difficult to
establish what should be preferred, as different sources (e.g. parent,
self, official records) have different advantages and disadvantages.
Interestingly, one longitudinal study reviewed here found that DNAm
patterns associated with maltreatment differed when using prospective,
independent reports of maltreatment in childhood compared to self-
reported retrospective measures of the same participants in adulthood
(Marzi et al., 2018). Ideally, future studies should use multi-rater
assessments of maltreatment to enable more systematic comparison of
DNAm patterns across reporting methods.
4.2.1.2. Adjust for appropriate covariates. As already done in other areas
of research such as population epigenomics (Felix and Cecil, 2019),
studies should always aim to report first findings from a baseline model
that adjusts for core covariates that are standard in the field (thus
facilitating comparability across studies), including technical covariates
(e.g. batch effects), sex, age, cell-type composition, and population
stratification for ethnically mixed samples. Depending on the research
question and study design, researchers may then choose to rerun
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analyses with an additional set of covariates that may relate to both
maltreatment exposure and DNAm for sensitivity purposes, such as
socio-economic status, tobacco smoking, and body mass index.
4.2.1.3. Make reporting more transparent. We encourage researchers to
adopt a more transparent and reproducible way of reporting results,
which will facilitate future re-use of summary data for the purposes of
replication, meta-analyses and secondary data analysis. Such practices
should include (i) providing annotated scripts (e.g. from R, Stata or
SPSS) of the analyses performed; (ii) making all results fully available
(e.g. EWAS genome-wide summary statistics included as supplementary
material or uploaded on a public repository); (iii) avoiding an over-
reliance on p-values and significance levels, by also reporting effect
sizes and confidence intervals that can aid interpretation of findings;
and (iv) reporting key statistics needed for meta-analyses, such as the
direction and strength of effects, as well as standard errors.
4.2.1.4. Push towards collaborative science. Finally, as a growing field
we must embrace collaborative science in order to increase our power
to detect what are likely to be subtle associations between maltreatment
and DNAm, maximize our ability to identify robust effects and weed out
false positives. These issues are particularly pertinent to research on
maltreatment, as studies tend to be understandably small, especially
when based on high-risk samples. Coordinated efforts, such as the
establishment of consortia, will mark a crucial step in achieving this
goal by connecting different research groups around the world,
facilitating knowledge exchange and multi-disciplinary collaboration
as well as establishing best practices for data harmonization and
common analytical pipelines. Ultimately, this will enable the pooling
of resources to perform better powered, multi-sample studies. Such
efforts have already proven to be successful in other areas of epigenetic
research, with active consortia currently dedicated for example to
understanding the genetic basis of DNAm (e.g. GoDMC; http://www.
godmc.org.uk); examining prenatal influences on child DNAm (e.g.
PACE; https://www.niehs.nih.gov/research/atniehs/labs/epi/pi/
genetics/pace/index.cfm); and identifying epigenetic markers of
cardiovascular and ageing-related disease (e.g. CHARGE; http://www.
chargeconsortium.com/).
4.2.2. Challenge 2: tackling the issues of directionality and confounding to
characterize maltreatment effects with greater precision
The vast majority of studies reviewed here were based on cross-
sectional data, with maltreatment exposure and DNAm measured at the
same time point. Such a design reflects often inherent difficulties in
carrying out research on maltreatment – especially in children and
high-risk samples – including ethical constraints and difficulties in
following maltreated individuals longitudinally. Yet, it also poses two
major challenges: directionality and confounding. Based on cross-sec-
tional data alone, it is not possible to establish whether observed DNAm
alterations precede, follow, or simply correlate with maltreatment ex-
posure. For example, maltreatment-associated DNAm patterns may re-
flect in part other preceding or concurrent environmental exposures
that are not accounted for in analyses. Indeed, maltreatment is known
to correlate with a range of prenatal adversities (e.g., maternal
smoking, substance use, psychopathology, exposure to stressful life
events and intimate partner violence; Austin et al., 2018), some of
which have already been linked to child DNAm patterns (e.g., Joubert
et al., 2016; Laufer et al., 2017). Even after birth, maltreated children
have been found to be more likely to experience additional adversities
(e.g. low SES, community violence exposure; Cecil et al., 2014) com-
pared to their non-maltreated peers, and to experience re-victimization
in different social contexts (e.g. bullying; Benedini et al., 2016) – ex-
posures which may partly explain or compound associations between
maltreatment and DNAm. Furthermore, it is well-established that dif-
ferent types of maltreatment co-occur, with multi-type exposure being
the norm rather than the exception for maltreated children (Cecil et al.,
2017; Herrenkohl and Herrenkohl, 2009). This, critically, is not ex-
plicitly modelled in epigenetic studies of maltreatment, where in-
dividual types of abuse and neglect are examined in isolation, without
accounting for their co-occurrence. In summary, based on cross-sec-
tional data, it is currently difficult to establish to what extent the
identified DNAm patterns may be due to unmeasured environmental
exposures, including prenatal factors, postnatal adversities or other co-
occurring types of maltreatment.
Besides the environment, genetic variation is likely to be another
important unmeasured influence. Although much of the interest in
epigenetics stems from its potential sensitivity to the environment, it is
also largely regulated by DNA sequence variation (Gaunt et al., 2016).
Indeed, many epigenetic processes that are essential for healthy de-
velopment and function, such as cell-type differentiation, genomic im-
printing and X-chromosome inactivation, are highly conserved and in-
fluenced by genetic factors. In the context of maltreatment, genetic
variation may affect observed associations in two main ways. First, as a
confounder. In this scenario, genetic factors could associate both with a
child’s risk for maltreatment as well as his or her DNAm patterns,
creating a spurious association between the two. Indeed, we already
know from other research that adversities such as stressful life events
(Clarke et al., 2018) and bullying (Schoeler et al., 2018) are sensitive to
genetic influences. In other words, rather than being randomly dis-
tributed across the population, social exposures may be more likely to
occur to certain individuals, partly because of their genetic background.
Thus, what can appear to be purely environmental exposures may ac-
tually contain a ‘genetic’ component. In the case of maltreatment, it is
possible for example that certain parental genetic characteristics that
increase risk of maltreatment (e.g. those influencing behavioral in-
hibition, emotional regulation, and psychiatric risk) get passed on to
children, and that these same characteristics associate with DNAm
patterns. This would result in an observed correlation between mal-
treatment and DNAm, which is genetically – as opposed to en-
vironmentally – explained.
The second way that genetics could influence maltreatment-DNAm
associations is as a moderator. Previous research has shown that genes
and the environment not only correlate with one another, but can also
interact. In other words, genes can influence how sensitive we are to
our environment, and in turn, our environment can influence the de-
gree to which our genes are expressed. In one of the first examples of
such gene-environment interactions (GxE), Caspi et al. (2002) found
that, amongst children with a history of maltreatment, those who car-
ried the ‘low-activity’ allele of the monoamine oxidase A (MAOA) gene
– conferring a reduced ability to break down neurotransmitters, such as
dopamine and serotonin – showed the most severe levels of antisocial
behavior compared to children who carried the ‘high-activity’ geno-
type. Since this early report of GxE, a large body of research has pro-
vided empirical support for the idea that an individual’s genetic ma-
keup can moderate his or her response to external events, partially
explaining why people exposed to the same stressor can react in very
different ways (Manuck and McCaffery, 2014). These findings have
recently been extended to epigenetics, showing that gene-environment
interactions largely account for individual variation in DNAm patterns
(Czamara et al., 2019; Teh et al., 2014). As such, associations between
maltreatment and DNAm may vary as a function of an individual’s
genetic makeup, which may help to explain some of the inconsistencies
in findings reported in this review.
Finally, observed associations may reflect the sequelae of maltreat-
ment, rather than maltreatment exposure per se – particularly in studies
based on adults where the time elapsed since the exposure is greater.
For example, maltreatment engenders risk for a wide range of negative
outcomes, including psychopathology, substance use, risky behaviors
and cardiometabolic disorders (e.g., Green et al., 2010; M. O. Murphy
et al., 2017). In turn, these outcomes have been associated with al-
terations in DNA (Cecil et al., 2015; Costantino et al., 2018; Torsten
Klengel and Binder, 2015). This problem is well-exemplified in several
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studies reviewed here, whereby the strongest DNAm sites associated
with maltreatment were found to be located in the AHRR gene– a
known epigenetic biomarker for tobacco smoking – as well as other
genes robustly associated with smoking (e.g., Marzi et al., 2018;
O’Donnell et al., 2018). While these findings suggest confounding by
smoking status, they also point to a potentially important mechanism
through which maltreatment exposure may affect biological function
and downstream health outcomes. Besides the sequelae of maltreat-
ment, DNAm patterns may also be affected by the use of medication to
treat these sequelae (Lötsch et al., 2013), a variable that is seldom
controlled for in epigenetic studies on adversity.
To address the issues of directionality and confounding illustrated in
this section, we list here five strategies that can be leveraged to measure
maltreatment effects with greater precision. We acknowledge that some
of these may be particularly difficult to implement in the context of
maltreatment research, and provide tools and resources that we hope
will facilitate these efforts.
4.2.2.1. Utilize prospective, longitudinal designs. Prospective designs,
whereby children are followed across development (ideally from
pregnancy onward), can help to disentangle the direction of effects
between maltreatment exposure and DNAm, as these variables are
collected in temporal order. When measured repeatedly, it additionally
becomes possible to examine how environmental adversities and DNAm
interrelate over time, and whether sensitive windows of development
exist whereby the effects of adversity on DNAm are strongest.
Furthermore, such studies enable to correct for the influence of
preceding exposures, for example by adjusting for prenatal
environmental factors or DNAm patterns at birth, which can be used
as a proxy for ‘baseline’ (i.e. pre-maltreatment) methylation levels. A
number of large prospective birth-cohorts already exist that have
followed children from pregnancy, have collected data on
maltreatment, and feature repeated measures of DNAm and other
adversities over time. These include the Generation R Study
(Kooijman et al., 2016) and the Avon Longitudinal Study of Parents
and Children (Boyd et al., 2019), both of which have open policies for
collaboration. Procedures for data request can be found in the following
links (https://generationr.nl/researchers/collaboration/; http://www.
bristol.ac.uk/alspac/researchers/access/).
4.2.2.2. Measure correlated exposures. Researchers are encouraged to
measure concurrent exposures correlated with maltreatment, including
socio-economic status and violence exposure across multiple settings,
spanning peers, partners and the wider community. This will enable to
test to what extent maltreatment-associated DNAm may be explained
by co-occurring exposures. In addition, researchers must ensure that all
main forms of maltreatment are measured (e.g. emotional, sexual and
physical abuse; emotional and physical neglect; exposure to intimate
partner violence), ideally using continuous assessments, so as
characterize the shared vs unique ‘signatures’ of maltreatment types.
This is a valuable question to clarify, as there is mounting evidence that
‘threatening’ forms of maltreatment (e.g. abuse) may trigger different
biological, neural and behavioral adaptations compared to forms of
maltreatment marked by ‘deprivation’ (e.g. neglect; McLaughlin et al.,
2014). Against this backdrop, it is important to note that the use of
more detailed, comprehensive phenotyping brings about its own set of
challenges, as it complicates efforts to carry out large, well-powered
studies. Indeed, large samples – such as those from population-based
cohorts – typically feature less detailed measures of maltreatment and
co-occurring exposures compared to smaller, more selected samples.
One approach to balance adequate statistical power with detailed
phenotyping is the aforementioned call for consortia focused around
epigenetics and maltreatment, although in order to be successful, this
endeavor will require careful harmonization of data.
4.2.2.3. Account for genetic influences. A key priority for future research
will be to better account for genetic influences, in order to minimize
confounding and to more accurately capture environmental effects on
the epigenome. This is imperative given recent evidence that most
inter-individual variation in DNAm is explained by genetic main effects
and gene-environment interactions, as opposed to ‘purely’
environmental effects (Czamara et al., 2019; Teh et al., 2014).
Consequently, it is currently unclear to what extent conducting
DNAm studies on maltreatment in the absence of genotypic
information provides meaningful information, as associations may
vary depending on genetic background. Accounting for genetic
influences can be done in several ways. One is to use genetically-
sensitive designs, such as twin studies (e.g. the E-Risk study; Fisher
et al., 2015), which enable to ‘isolate’ environmental influences on
DNAm while controlling for genetic similarity between twins. Another
is to actually measure DNA sequence variation, making it possible to
directly control for genetic influences in the analyses, as well as to test
for potential genetic moderation (e.g. either at the SNP-level if sample
sizes allow, or by using polygenic scores). More broadly, the use of
genetic data on methylation quantitative trait loci (mQTLs; i.e. SNPs
that influence DNAm levels either proximally in cis or distally in trans;
Gaunt et al., 2016) opens new and exciting opportunities within the
field of environmental epigenetics, as a way of integrating genetic and
environmental influences on the epigenome. Such an approach,
however, will necessitate the development of innovative
bioinformatics tools as well as simulation work to inform sample sizes
that are needed to reach adequate statistical power for modelling GxE
effects. Finally, in cases where DNA data is not available, it is possible
to indirectly examine genetic influences via the use of publicly
accessible online resources. Two of these are the ARIES mQTLdb
resorce (http://www.mqtldb.org/ ; Gaunt et al., 2016), based on
1000 mother-child pairs with genetic and longitudinal epigenetic data
from the ALSPAC cohort, and GoDMC (http://www.godmc.org.uk/;
Bonder et al., 2017), a consortium effort to uncover the genetic basis of
DNAm using pooled data from over twenty research groups. Both
resources allow researchers to check whether their DNAm sites of
interest are known to be influenced by common genetic polymorphisms
(available for CpG sites covered by the Illumina 450k array).
Researchers can also access heritability estimates from twin studies to
look up the proportion of variance of a particular CpG that is explained
by additive genetic influences vs shared and non-shared environmental
influences (https://www.epigenomicslab.com/online-data-resources/;
Hannon et al., 2018). While online resources cannot clarify what
specific role genetic variation plays in the relationship between
maltreatment and DNAm, they can provide useful insights into the
extent to which genetic influences may be involved.
4.2.2.4. Build integrative models. Studies that measure maltreatment,
DNAm and individual outcomes (e.g. psychiatric disorders), should
routinely aim to integrate this information within a single model, in
order to test (i) unique associations between these variables, and,
importantly (ii) the extent to which DNAm may mediate maltreatment
effects on individual outcomes. While a number of the studies reviewed
here did formally test for mediation, analyses were based on cross-
sectional data. In future, mediation models should be performed on
longitudinal data that follows the hypothesized temporal order of
associations (i.e. maltreatment → DNAm → outcomes), minimizing
issues of reverse causality. Please refer to the review by Barker et al.
(2018) for empirical examples of longitudinal integrative models
featuring environmental exposures, DNAm data, and individual
outcomes.
4.2.2.5. Apply causal inference methods. Although longitudinal data can
help to clarify the direction of effects between maltreatment and
DNAm, it is still based on a correlational design, which is vulnerable
to confounding and precludes inferences regarding causality. In future,
it will become increasingly important to test the extent to which
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maltreatment exposure causes changes in DNAm, and whether such
changes in turn cause downstream negative health outcomes. While
certain methods that have been proposed for strengthening causal
inference (e.g. Mendelian randomization) may be particularly
challenging to apply in the case of maltreatment, as they require the
use of genetic proxies for the exposure under consideration, other
methods may be more feasible. Examples include the use of negative
controls, quasi-experimental designs and non-genetic instrumental
variables, as well as cross-cohort and cross-species comparisons (see
Richmond et al., 2014a,2014b for an overview). Ideally, research
should be based on a combination of these strategies to allow for
triangulation of results, as each method has its own strengths and
limitations.
4.2.3. Challenge 3: improving our understanding of the epigenome
The last challenge we want to highlight is more biological, in that
we still know very little about the epigenome itself. First, even though
commonly available array technologies, such as the Illumina450k array
(or the more recent Illumina EPIC array), allow us to measure DNAm
levels across hundreds of thousands of CpG sites, they only cover 2–4 %
of CpG sites across the genome. Second, this data is typically analyzed
in ‘two-dimensional’ space (one value per CpG site along the genome),
which does not adequately reflect the three-dimensional organization of
DNA, whereby certain regions seemingly distant from one another (e.g.
on different parts of a chromosome) may actually physically interact
with one another. Third, DNAm is only one of several epigenetic me-
chanisms that work in concert, including histone modifications and
non-coding regulatory RNAs. As such, we are only able at present to
capture a small snapshot of a much bigger picture that may be relevant
for understanding the epigenetic embedding of maltreatment exposure.
To complicate matters, DNAm is dynamic, varying across factors such
as age, sex, tissue and cell-type. This makes it challenging to char-
acterize how an exposure like maltreatment may impact epigenetic
patterns at a given point in time, or in a given type of cell within the
body. It also means that DNAm patterns found to associate with mal-
treatment using easily accessible peripheral tissues, such as saliva or
blood, may not reflect what is happening in the brain – likely the most
relevant organ for the study of maltreatment and its sequelae (e.g.
psychiatric disorders). This is especially relevant in the case of DNA
hydroxymethylation – a more recently discovered epigenetic process
that plays a role in numerous brain functions, including neurodeve-
lopment (Spiers et al., 2017), and has been linked to adversity in ex-
perimental studies (Massart et al., 2014). Because DNA hydro-
xymethylation is enriched in brain tissue, but not in peripheral tissues,
and because widely used methods for epigenotyping are unable to
distinguish it from DNA methylation, it is currently a particularly dif-
ficult epigenetic marker to study in human populations (Doherty and
Roth, 2018). While post-mortem studies can help us to reach a more
mechanistic view of the effects of maltreatment on epigenetic regula-
tion in the brain, these too suffer from a number of limitations, in-
cluding the use of small samples with mixed clinical presentation, the
reliance on cross-sectional data, difficulties assessing maltreatment
exposure and incomplete phenotyping (see Bakulski et al., 2016 for a
review). Overall, research to date comparing multiple peripheral and
brain tissues has found that although DNAm patterns are largely tissue
and cell-type specific, a considerable proportion of DNAm sites – par-
ticularly those that are highly-variable – show cross-tissue concordance
(e.g. Hannon et al., 2015; Islam et al., 2019; Smith et al., 2015). A
handful of studies included in this review also found concordant asso-
ciations between maltreatment and DNAm across multiple tissues
(Hecker et al., 2017; Houtepen et al., 2016; Kaminsky et al., 2015) –
although all focused on single genes so correspondence in genome-wide
DNAm patterns in relation to maltreatment is presently unknown. Fi-
nally, it is unclear to what extent statistical associations between mal-
treatment and DNAm imply a functional effect. In other words, ob-
served associations can be highly significant, but involve very small
changes in DNAm levels, with unknown biological consequence. To
move towards a more biologically informed approach, we provide the
following recommendations:
4.2.3.1. Make use of cross-tissue designs and tools. Although the focus on
single tissue sources can provide valuable insights (e.g. examining
blood given its potential role in neuroimmunology or buccal cells given
that they originate from the same germ layer as the brain), ideally,
studies should aim to collect DNA from multiple tissue sources, in order
to establish the extent to which maltreatment-related DNAm patterns
may be tissue-specific vs systemic. Furthermore, studies should seek to
bridge findings from peripheral tissues in living individuals with those
based on post-mortem brain samples. When such strategies may not be
feasible, for example due to cost and logistic constraints, researchers
may draw on publicly available resources to help make cross-tissue
inferences. For example, several freely accessible resources exist that
enable researchers to compare how DNAm levels in CpG sites of interest
correlate between peripheral and brain tissue (e.g., https://han-lab.
org/methylation/default/imageCpG#, Braun et al., 2019; https://
redgar598.shinyapps.io/BECon/, Edgar et al., 2017; http://
epigenetics.iop.kcl.ac.uk/bloodbrain/, Hannon et al., 2015), some of
which also provide useful metrics in addition to cross-tissue
correlations, such as the degree of variability and influence of cell-
type composition on DNAm in blood vs brain (Edgar et al., 2017). It is
important to note here, that peripheral DNAm patterns may still be
useful within research and practice even in the absence of cross-tissue
concordance with the brain. For example, peripheral tissues may be the
most suitable target for studying other biological systems that have
been found to be dysregulated in response to maltreatment, such as
immune, cardiovascular and metabolic function (Berens et al., 2017).
Furthermore, to be useful markers, DNAm patterns need not to show
cross-tissue correspondence, so long as they are reliably and robustly
associated with the exposure or outcome of interest (Felix and Cecil,
2019).
4.2.3.2. Test functional effects at different biological levels. It will be
important in future to integrate DNAm data with information at other
biological levels in order to test the functional effect of maltreatment-
associated epigenetic changes. Again, this may be done directly, by
profiling gene expression and additional omics data from the same
samples as the DNAm. Indeed, procedures for co-ordinated RNA and
DNA extraction are now widely available, which enable to assess
concurrently epigenetic and transcriptional activity from the same
biological samples (although at a higher cost than kits for DNA
extraction only). The study by Lutz and colleagues (2017), provides a
compelling example of how integration of biological data can provide
key insights into the functional role of maltreatment-related epigenetic
patterns. In cases where such data is not available, researchers may use
online resources to check whether the identified DNAm loci overlap
with established key regulatory elements, such as transcription factor
binding sites, hypersensitive genomic regions and histone marks (e.g.
using data from ENCODE: http://genome.ucsc.edu/ENCODE/ and
ROADMAP: http://www.roadmapepigenomics.org/tools). More work
is also needed to clarify the biological pathways linking maltreatment,
epigenetics and mental health. One approach is to examine how
maltreatment-related DNAm changes associate with intermediate
phenotypes of psychiatric risk. To this end, an increasing number of
studies are utilizing neuroimaging data to examine how DNAm patterns
of interest may relate to in vivo brain structure and function in circuits
implicated in psychopathology (Walton et al., 2017; Vukojevic et al.,
2014). In future, it will be interesting to test whether peripheral DNAm
sites associated with brain structure and function also show higher
cross-tissue concordance, making them potentially useful markers of
brain processes in vivo.
4.2.3.3. Collaborate with fundamental scientists. Finally, researchers in
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the field of maltreatment are encouraged to connect with fundamental
scientists to help gain biological insights and enhance interpretation of
their findings. For example, researchers may seek to collaborate with
others carrying out animal models and in vitro experiments (e.g. cell
cultures), which permit experimental manipulation of DNAm levels to
characterize downstream functional effects. Such multi-disciplinary
partnerships can be equally fruitful for fundamental scientists, who
are often faced with the challenge of establishing how findings from
their highly controlled, experimental conditions extend to humans in
more naturalistic and ecologically-valid settings. For advice on ways to
facilitate collaboration between animal and human studies of early life
stress, we recommend the review by Watamura and Roth (2019).
4.3. Implications and translational potential
In conclusion, DNA methylation is fast emerging as a promising
mechanism for biological embedding of maltreatment exposure. Yet, as
we gain an appreciation of the challenges facing epigenetic research in
this field, we must be mindful to manage expectations. In future, the use
of strategies such as (i) careful selection of research design (e.g. ap-
propriate tissue, sample size, time points); (ii) use of longitudinal and
integrative data, (iii) consideration of unmeasured environmental and
genetic influences, (iv) transparency in reporting and replication, (v)
functional characterization of epigenetic findings, and (vi) the appli-
cation of causal inference methods, will mark an important step for
overcoming current hurdles and moving the field forward. Bearing this
in mind, the knowledge generated from epigenetic studies may hold
important implications for the way that we understand – and in future
perhaps even intervene on – childhood maltreatment and its sequelae.
In the first instance, findings may be used to refine existing models
of maltreatment. For example, DNAm may help us to better understand
how environmental exposures, such as maltreatment, interact with
genetic factors to shape long-term trajectories of child development,
behavior and disease risk. DNAm may also help us to understand how
the body adapts to adverse, threatening and unpredictable early en-
vironments – and how such adaptations may be potentially protective
in the short-term, but detrimental in the long-term. Finally, DNAm can
provide a mechanism for latent vulnerability; in other words, how
maltreatment engenders vulnerability for psychiatric and physical
health problems even decades after the exposure itself has ceased.
In the medium-term, as replication efforts increase and meta-ana-
lyses become more feasible, it may be possible to identify robust and
reproducible associations between maltreatment exposure and DNAm.
This could pave the way for a new wave of studies testing the potential
of DNAm as a biomarker of maltreatment exposure across clinical and
research settings. Such a biomarker could be used, for example, to
overcome issues common to other reporting methods of maltreatment
(e.g. recall bias) and to inform risk assessment and treatment for-
mulation. Furthermore, the comparison of DNAm pre- vs post-inter-
vention (e.g. via environmental enrichment, psychological therapy,
etc), could lend insights into the potential reversibility of maltreatment-
related patterns and how best to promote resilience among exposed
individuals. Indeed, a small number of prospective studies to date have
utilized repeated sampling of DNAm to predict clinical outcomes. These
have shown, for example, that changes in DNAm patterns associate with
symptom severity following a traumatic exposure (e.g. military de-
ployment, Rutten et al., 2018), but also with symptom change following
psychological intervention (e.g. Roberts et al., 2018; Yehuda et al.,
2013; Ziegler et al., 2016). Longitudinal research that investigates the
timing of maltreatment effects on epigenetic regulation could also be
used to identify specific windows of biological vulnerability or oppor-
tunity that could benefit most from preventive action. Any potential
benefit of DNAm as a biomarker, however, would likely also be ba-
lanced by potential risks, raising important ethical implications that
would need careful consideration and safeguarding. Ultimately, estab-
lishing causal pathways between childhood maltreatment and DNAm
could lead to the development of novel strategies for alleviating the
societal burden of maltreatment and treating its psychological and
physical sequelae.
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